Siga Technologies INC Debtor Reorganization Items, Other Expense (Income)
Siga Technologies INC (SIGA) reported Debtor Reorganization Items, Other Expense (Income) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtorReorganizationItemsOtherExpenseIncome · last filed 2018-03-06
- Siga Technologies INC debtor reorganization items, other expense (income) for the quarter ending 2016-12-31 was $0.00.
- Siga Technologies INC debtor reorganization items, other expense (income) for the quarter ending 2016-09-30 was $0.00.
- Siga Technologies INC debtor reorganization items, other expense (income) for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC debtor reorganization items, other expense (income) for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC debtor reorganization items, other expense (income) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Siga Technologies INC debtor reorganization items, other expense (income) for fiscal 2015 was $5.67K, a 92.60% decline from fiscal 2014.
- Siga Technologies INC debtor reorganization items, other expense (income) for fiscal 2014 was $76.60K.
| Period end | Debtor Reorganization Items, Other Expense (Income) 3 month | Debtor Reorganization Items, Other Expense (Income) 6 month | Debtor Reorganization Items, Other Expense (Income) 9 month | Debtor Reorganization Items, Other Expense (Income) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | $0.00 derived: sum of 3 quarters · filed 2018-03-06 | $0.00 10-K · filed 2018-03-06 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-06 | $0.00 derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | $0.00 derived: sum of 3 quarters · filed 2018-03-06 | $3.13K derived: sum of 4 quarters · filed 2018-03-06 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | $3.13K derived: sum of 3 quarters · filed 2018-03-06 | $5.67K 10-K · filed 2018-03-06 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-02 | $3.13K derived: sum of 2 quarters · filed 2016-11-02 | $5.67K 10-Q · filed 2016-11-02 | $12.27K derived: sum of 4 quarters · filed 2016-11-02 |
| 2015-06-30 | $3.13K 10-Q · filed 2016-08-08 | $5.67K 10-Q · filed 2016-08-08 | $12.27K derived: sum of 3 quarters · filed 2016-08-08 | $82.27K derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | $2.54K 10-Q · filed 2016-05-04 | $9.14K derived: sum of 2 quarters · filed 2016-05-04 | $79.14K derived: sum of 3 quarters · filed 2016-05-04 | |
| 2014-12-31 | $6.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $76.60K derived: sum of 2 quarters · filed 2016-03-04 | $76.60K 10-K · filed 2016-03-04 | |
| 2014-09-30 | $70.00K 10-Q · filed 2015-10-27 | $70.00K 10-Q · filed 2015-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |